| http://purl.uniprot.org/citations/29382358 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/29382358 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundThe Fos-related antigen 1 (FRA-1) transcription factor promotes tumor cell growth, invasion and metastasis. Phosphorylation of FRA-1 increases protein stability and function. We identify a novel signaling axis that leads to increased phosphorylation of FRA-1, increased extracellular matrix (ECM)-induced breast cancer cell invasion and is prognostic of poor outcome in patients with breast cancer.MethodsWhile characterizing five breast cancer cell lines derived from primary human breast tumors, we identified BRC-31 as a novel basal-like cell model that expresses elevated FRA-1 levels. We interrogated the functional contribution of FRA-1 and an upstream signaling axis in breast cancer cell invasion. We extended this analysis to determine the prognostic significance of this signaling axis in samples derived from patients with breast cancer.ResultsBRC-31 cells display elevated focal adhesion kinase (FAK), SRC and extracellular signal-regulated (ERK2) phosphorylation relative to luminal breast cancer models. Inhibition of this signaling axis, with pharmacological inhibitors, reduces the phosphorylation and stabilization of FRA-1. Elevated integrin αVβ3 and uPAR expression in these cells suggested that integrin receptors might activate this FAK-SRC-ERK2 signaling. Transient knockdown of urokinase/plasminogen activator urokinase receptor (uPAR) in basal-like breast cancer cells grown on vitronectin reduces FRA-1 phosphorylation and stabilization; and uPAR and FRA-1 are required for vitronectin-induced cell invasion. In clinical samples, a molecular component signature consisting of vitronectin-uPAR-uPA-FRA-1 predicts poor overall survival in patients with breast cancer and correlates with an FRA-1 transcriptional signature.ConclusionsWe have identified a novel signaling axis that leads to phosphorylation and enhanced activity of FRA-1, a transcription factor that is emerging as an important modulator of breast cancer progression and metastasis."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.org/dc/terms/identifier | "doi:10.1186/s13058-018-0936-8"xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/author | "Mes-Masson A.M."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/author | "Siegel P.M."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/author | "Andrechek E.R."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/author | "Annis M.G."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/author | "Rancourt C."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/author | "Ouellet V."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/author | "L'Esperance S."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/author | "Rennhack J.P."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/date | "2018"xsd:gYear |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/name | "Breast Cancer Res"xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/pages | "9"xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/title | "Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion."xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://purl.uniprot.org/core/volume | "20"xsd:string |
| http://purl.uniprot.org/citations/29382358 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/29382358 |
| http://purl.uniprot.org/citations/29382358 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/29382358 |
| http://purl.uniprot.org/uniprot/#_E9PKL5-mappedCitation-29382358 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29382358 |
| http://purl.uniprot.org/uniprot/#_E9PPX2-mappedCitation-29382358 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29382358 |
| http://purl.uniprot.org/uniprot/#_P15407-mappedCitation-29382358 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29382358 |
| http://purl.uniprot.org/uniprot/#_A0A0S2Z595-mappedCitation-29382358 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29382358 |
| http://purl.uniprot.org/uniprot/#_B2R9B4-mappedCitation-29382358 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29382358 |
| http://purl.uniprot.org/uniprot/#_B4DDQ7-mappedCitation-29382358 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29382358 |
| http://purl.uniprot.org/uniprot/#_Q53GM9-mappedCitation-29382358 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29382358 |